|
⚲
|
| Keyboard |
| Aryeh Jason
✚
|
|
|---|---|
| CIK # | 0001376960 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001376960] | |
| 4 | [0001376960] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2025-12-08 | Option exercise | 2,034 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-12-08 | Option exercise | 2,034 | $69.51 | 141,383 |
|
Health Sciences Acquisitions Corp 2 OBIO
"Common Stock, par value $0.0001 per share (""Common Stock"")"
|
2025-08-07 | Grant | 15,000 | $0.00 | |
|
Lifecore Biomedical Inc de LFCR
Common Stock
|
2025-07-15 | Grant | 19,506 | ||
|
Health Sciences Acquisitions Corp 2 OBIO
Stock Option (Right to Buy) · derivative
|
2025-06-24 | Grant | 36,797 | $0.00 | |
|
Health Sciences Acquisitions Corp 2 OBIO
"Common Stock, par value $0.0001 per share (""Common Stock"")"
|
2025-06-24 | Grant | 12,422 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-06-06 | Grant | 1,209 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2025-06-06 | Grant | 5,783 | $0.00 | |
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2025-04-04 | Grant | 25,000 | $0.00 | |
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2025-04-04 | Grant | 4,964 | $0.00 | |
|
Health Sciences Acquisitions Corp 2 OBIO
Stock Option (Right to Buy) · derivative
|
2024-12-27 | Option exercise | 11,700 | $0.00 | |
|
Health Sciences Acquisitions Corp 2 OBIO
"Common Stock, par value $0.0001 per share (""Common Stock"")"
|
2024-12-27 | Option exercise | 11,700 | $4.30 | 50,310 |
|
Lifecore Biomedical Inc de LFCR
Common Stock
|
2024-08-19 | Grant | 24,554 | ||
|
Health Sciences Acquisitions Corp 2 OBIO
Stock Option (Right to Buy) · derivative
|
2024-06-20 | Grant | 17,068 | $0.00 | |
|
Health Sciences Acquisitions Corp 2 OBIO
"Common Stock, par value $0.0001 per share (""Common Stock"")"
|
2024-06-20 | Grant | 5,376 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2024-06-14 | Grant | 5,444 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-06-14 | Grant | 1,252 | $0.00 | |
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2024-06-13 | Grant | 41,667 | $0.00 | |
|
Anebulo Pharmaceuticals Inc ANEB
Stock Option (right to buy) · derivative
|
2024-06-13 | Grant | 2,482 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-04-30 | Option exercise | 2,406 | $52.30 | 125,834 |
| showing 20 of 194 most recent transactions | |||||